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Background: Moderate-severe traumatic brain injury (TBI) is increasingly being
understood as a progressive disorder, with growing evidence of reduced brain volume
and white matter (WM) integrity as well as lesion expansion in the chronic phases of
injury. The scale of these losses has yet to be investigated, and pattern of change across
structures has received limited attention.
Objectives: (1) To measure the percentage of patients in our TBI sample showing
atrophy from 5 to 20 months post-injury in the whole brain and in structures with known
vulnerability to acute TBI, and (2) To examine relative vulnerability and patterns of volume
loss across structures.
Methods: Fifty-six TBI patients [complicated mild to severe, with mean Glasgow
Coma Scale (GCS) in severe range] underwent MRI at, on average, 5 and 20 months
post-injury; 12 healthy controls underwent MRI twice, with a mean gap between scans
of 25.4 months. Mean monthly percent volume change was computed for whole brain
(ventricle-to-brain ratio; VBR), corpus callosum (CC), and right and left hippocampi (HPC).
Results: (1) Using a threshold of 2 z-scores below controls, 96% of patients showed
atrophy across time points in at least one region; 75% showed atrophy in at least 3
of the 4 regions measured. (2) There were no significant differences in the proportion
of patients who showed atrophy across structures. For those showing decline in VBR,
there was a significant association with both the CC and the right HPC (P < 0.05 for both
comparisons). There were also significant associations between those showing decline in
(i) right and left HPC (P < 0.05); (ii) all combinations of genu, body and splenium of the CC
(P < 0.05), and (iii) head and tail of the right HPC (P < 0.05 all sub-structure comparisons).
Conclusions: Atrophy in chronic TBI is robust, and the CC, right HPC and left HPC appear
equally vulnerable. Significant associations between the right and left HPC, and within
substructures of the CC and right HPC, raise the possibility of common mechanisms
for these regions, including transneuronal degeneration. Given the 96% incidence rate
of atrophy, a genetic explanation is unlikely to explain all findings. Multiple and possibly
synergistic mechanisms may explain findings. Atrophy has been associated with poorer
functional outcomes, but recent findings suggest there is potential to offset this. A better,
understanding of the underlying mechanisms could permit targeted therapy enabling
better long-term outcomes.
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INTRODUCTION
Traumatic brain injury (TBI) is increasingly being understood as
a chronic and possibly progressive disease, rather than an injury
with a circumscribed period of recovery and a static course there-
after (Ng et al., 2008; Masel and Dewitt, 2010; Bigler, 2013a).
Evidence is accumulating from several laboratories including
our own that following early cognitive recovery, many patients
show statistically and clinically significant cognitive decline in
the ensuing months (Ruff et al., 1991) and years (Millis et al.,
2001; Till et al., 2008). We and others have also demonstrated
that the brain’s structure is not static after resolution of acute
injuries, with TBI patients showing volume loss and reduced
white matter (WM) integrity during the sub-acute and chronic
stages of injury (Bendlin et al., 2008; Greenberg et al., 2008;
Ng et al., 2008; Sidaros et al., 2009; Farbota et al., 2012; Adnan
et al., 2013). Given that such atrophy is observed in some studies
Frontiers in Human Neuroscience www.frontiersin.org March 2014 | Volume 8 | Article 67 | 1
HUMAN NEUROSCIENCE
Green et al. TBI atrophy, scale, and pattern
well after the resolution of acute events (Greenberg et al., 2008;
Ng et al., 2008; Ross et al., 2012), and that sub-acute structural
deterioration has been correlated with functional and behav-
ioral outcomes (Bendlin et al., 2008; Sidaros et al., 2009), these
changes cannot be attributed simply to encephalomalacia (i.e.,
scar formation associated with gliosis) or to resolution of edema.
The evidence is thus supportive of a progressive neuropathol-
ogy, possible mechanisms of which have been recently reviewed
(Smith et al., 2013).
This very different course of TBI than has been traditionally
assumed has clinical and scientific implications for howwe under-
stand and treat TBI patients, in both the short and longer term.
Therefore, it is important to gain an understanding of the scale
of atrophy: What proportion of TBI patients demonstrates pro-
gressive loss of brain volume? Previous studies have demonstrated
group differences in atrophy and/or WM integrity loss between
TBI patients and controls. What has yet to be investigated is the
actual prevalence of patients who show decline, and moreover,
who do so at what might be considered a clinically significant
degree. Such information is needed to understand whether it is
a subset of TBI patients who are at risk of degeneration or the
majority. While atrophy in a subset would direct researchers (and
clinicians) to evaluate risk factors for degeneration; ubiquitous
atrophy would suggest that TBI itself is a degenerative disorder.
The central aim of this study, therefore, was to begin to shed light
on this question of scale.
To address the question, we undertook volumetric MRI mea-
surements in TBI patients at approximately 5 and 20 months
post-injury and compared the extent of volume loss across
time for each patient to a normative control sample, also
measured at two time points. We called patients showing sig-
nificant volume loss “decliners.” In both samples, we exam-
ined the whole brain using ventricle-to-brain ratio (VBR), as
well as the hippocampi and corpus callosum (CC) and their
sub-structures, areas with demonstrated vulnerability to the
acute mechanical and neurochemical effects of injury (e.g.,
axonal deformation, hypoxia, excitotoxic cascades Povlishock
and Katz, 2005). Our cohort ranged in severity from compli-
cated mild to severe, but was overall a severely injured group of
patients.
With regard to prediction of the scale of atrophy, in a previous
study in which we examined lesion expansion, we found that in
our sample of 14 patients, 10 showed lesion expansion across time
within the chronic stages of injury (Ng et al., 2008). We there-
fore predicted that at least half of our sample in the current study
would show significant volume loss on at least one measure.
We were also interested in the relative vulnerability of the
individual structures and sub-structures, and in their pattern of
deterioration. With regard to relative vulnerability, we measured
the number of decliners (i.e., people who showed atrophy across
time points as compared to normative controls) for each struc-
ture in order to ascertain whether one structure showed a greater
frequency of decliners than another structure.
We speculated that those regions most vulnerable to acute
injury would show the greatest chronic atrophy. This is because
of growing evidence that while “use” increases brain (and in par-
ticular hippocampal) volume (Draganski et al., 2006; Maguire
et al., 2006), “disuse” mediates volume loss (Underwood and
Coulson, 2008; Miller et al., 2013). Therefore, we reasoned that
regions most susceptible to initial damage, should sustain greater
disuse, and therefore greater later atrophy. Both the CC and
the hippocampi are commonly affected in TBI, especially when
rotational forces are involved. In one study in children, the hip-
pocampus was identified as the most vulnerable structure to TBI
(Wilde et al., 2006), and it is vulnerable to acute phase dam-
age from a variety of mechanisms, (e.g., mechanical deformation,
hypoxic/excitotoxic injury, afferent and efferent disconnection of
projections, and compromised neurogenesis Greer et al., 2012).
The hippocampal head has been shown to be disproportion-
ately vulnerable, as compared to the body and tail (Ariza et al.,
2006). We therefore predicted that more individuals would show
chronic degeneration in the hippocampal head than any other
structure/sub-structure examined.
With regard to the pattern of deterioration, we asked whether
the volumes of those regions measured in the study shrink com-
mensurately with one another, and whether their sub-regions
would shrink commensurately. In other words, did individu-
als who showed atrophy on one structure, also necessarily show
atrophy on another?
In our previous research into sub-acute cognitive decline (Till
et al., 2008), we observed marked variability in the cognitive
and psychomotor functions that showed decline from 12 to 24
months post-injury, both within and between subjects. This sug-
gested that atrophy might not have a predictable pattern. On this
basis, we predicted that decline in one region would not be asso-
ciated with decline in another, although we expected VBR—as an
index that subsumes all other structures—to be associated with
the hippocampi and CC.
MATERIALS AND METHODS
All participants gave their informed consent, except where par-
ticipants were clinically judged as unable to provide informed
consent; here, a substitute decision maker provided informed
consent. In such cases, all patients gave their assent to partici-
pate. The study was approved by the Research Ethics Board of the
Toronto Rehabiltation Institute where the research took place
PARTICIPANTS
TBI Patient group
Patient participants were 56 males and females with clinically
confirmed TBI. See Table 1 for injury and demographic charac-
teristics of the sample, which were ascertained through medical
records, clinical interview and direct testing. Overall, this was a
typical group of adult TBI patients with more males than females,
more motor-vehicle accidents than other causes of injury, esti-
mated pre-morbid IQ (as measured by the Wechsler Test of Adult
Reading (WTAR) Weschler, 2001; Green et al., 2008) in the aver-
age range, and just over high-school education. TBI severity for
participants was based on the lowest Glasgow Coma Scale (GCS)
score obtained from the acute care medical chart, where GCS
was available and valid, or from length of post-traumatic amne-
sia (PTA), which was obtained from medical records and/or from
clinical interview with the patient and family members at approx-
imately 2 months post-injury. PTA classifications were based on
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Table 1 | Injury and demographic characteristics of TBI sample
(N = 56).
Variable Proportion/mean SD (range)
Age (years) M = 40.16 15.63 (17–73)
Education (years) M = 13.63 3.36 (6–21)
Estimated pre-morbid IQ (WTAR)
(N = 51)
M = 98.45 18.26 (67–125)
Sex 73% = male
27% = female
SOCIO-ECONOMIC STATUS (BASED ON HOLLINGSHEAD
CLASSIFICATION Hollingshead and Redlich, 1958)
1. Major business/professional 3.8%
2. Medium business/minor
professional, technical
41.5%
3. Skilled craftsperson, clerical,
sales worker
17%
4. Machine operator, semiskilled
worker
18.9%
5. Unskilled laborer, menial
service worker
18.9%
TYPE OF INJURY
Motor vehicle accident 57.1%
Fall 37.5%
Assault 3.6%
Sports injury 1.8%
SEVERITY OF INJURY VARIABLES
Acute care length of stay (days) M = 37.44days 20.01 (5–98)
GCS (lowest of recorded scores) M = 6.19 3.42(3–13)
Mild (13–15) 10.7
Moderate (9–12) 5.4%
Severe (≤8) 69.6%
Missing data 14.3%
LENGTH OF POST-TRAUMATIC AMNESIA
Less then 5min, very mild 3.6%
1–24 h, moderate 1.8%
1–7 days, severe 21.4%
1–4 weeks, very severe 44.6%
>4 weeks, extremely severe 23.2%
Missing data 5.4%
Lezak (2004). As indicated in Table 1, patients ranged in severity
from complicated mild to severe or greater, with mean TBI
severity based on GCS in the severe range (M = 6.2).
All patient participants were recruited at a large, urban rehabil-
itation teaching hospital in Toronto from the in-patient Acquired
Brain Injury service. The patients were part of an ongoing,
prospective study on recovery from TBI (The Toronto Rehab
Traumatic Brain Injury Recovery Study), which includes cognitive,
motor, and neuro-imaging assessments at multiple time points.
Inclusion criteria for the larger study comprise: clinically con-
firmed TBI with central (as opposed to orthopedic) injuries severe
enough to warrant in-patient neurorehabilitation; out of PTA by
3 months post-injury; aged between 17 and 75; able to use at least
one upper extremity; and, functional command of English. An
additional inclusion criterion for the present study was comple-
tion of two or more MRIs. Exclusion criteria for the larger study
include: past history of TBI; history of psychotic or neurologi-
cal illness; and, TBI sustained secondary to another neurological
event (e.g., a stroke). An additional exclusion criterion for the
current study was an intervening neurological event between
the first and follow-up MRI with the potential to influence the
structural status of the brain (e.g., another TBI or intra-cranial
infection).
Healthy control group
Twelve healthy adult control participants were recruited to the
current study. These individuals were students and staff mem-
bers at the rehabilitation hospital or friends or family members
of students and staff members. Controls were excluded if they
had a previous history of TBI, including concussion, or any other
disease affecting the central nervous system. The control group
was 50% male, with a mean age of 36.3 years (SD = 12.5, range
18–60), and a mean education of 17.5 years (SD = 2.2, range
11–21).
DESIGN AND PROCEDURES
The study was a prospective, repeated measures design. The nor-
mative control group was used to establish the level of decline in
each patient for each structure. This was computed for each sub-
ject for each structure, as described below. MRIs were adminis-
tered at two time points. The first was completed for all patients at
a mean of 5.2 months post-injury, (SD = 1.15; range: 3.7–10.4).
The second scan was at a mean of 20 months post-injury (SD =
4.7; range = 10.5–56.1), with a mean gap between scans of
14.8 months (SD = 10.9; range = 4.4–52.2). For control partici-
pants, the mean gap between scans was 25.4 months (SD = 10.0;
range = 10.4–39.4). The relatively greater gap in the controls
biased hypotheses against Type I errors. The longer gap between
control scans allowed for greater non-specific decline to tran-
spire, thereby increasing the threshold for reaching decline in the
patients.
The MRI outcome measures were as follows: computed
monthly percent change for ventricle to brain ratio (VBR), vol-
umes of the left hippocampus (HPC-L; i.e., HPC-L total, HPC-L
head, HPC-L body, HPC-L tail), volumes of the right hippocam-
pus (HPC-R; i.e., HPC-R total, HPC-R head, HPC-R body, HPC-
R tail), and CC volumes (i.e., CC total, CC genu, CC body, CC
splenium).
All participants were required to pass a rigorous, clinical
screening procedure prior to the first MRI assessment. All MRIs
were conducted at a separate site (Toronto Western Hospital),
which is part of the same center. All equipment and acqui-
sition parameters were identical for the initial and follow-up
assessments. One of two MRI technologists performed all MRIs.
Acquisition protocol
MRI scans were acquired on a General Electric (GE) Signa-
Echospeed 1.5 Tesla HD scanner (SIGNA EXCITE, GE
Healthcare, Milwaukee WI), using an eight channel head
coil. Sequences included sagittal T1 (TR/TE = 300/13ms),
slice thickness = 5mm, space 2.5mm, matrix 256 × 128 axial
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gradient recalled echo (GRE) TR/TE = 450/20, flip angle = 20◦,
slice thickness = 3mm no gap, matrix 256 × 192 axial fluid-
attenuated-inversion-recovery (FLAIR) TR/TE = 9000/45ms,
TI (inversion time) = 2200ms, slice thickness = 5mm no gap,
matrix 256 × 192 axial fast spin echo (FSE) proton density
(PD)/T2 TR/TE 5500/30,90ms, slice thickness = 3mm no gap,
matrix 256 × 192. All above mentioned sequences were obtained
with a 22 cm field of view (FOV). The high-resolution isotropic
T1 weighted, three-dimensional IR prepped radio-frequency
spoiled-gradient recalled-echo (3D IRSPGR) images TI/TR/TE =
12/300/5,TI, FA = 20, slice thickness = 1mm no gap, matrix =
256 × 256 were acquired in the axial plane utilizing a 25 cm FOV.
The entire scanning session lasted approximately 55min.
Image processing and analysis
The MR images were transferred to a workstation for image
processing. The scans were received in the Digital Imaging
and Communications in Medicine (DICOM) file format and
were subsequently converted into (Medical Imaging Network
Common Data Form; MINC) file format that was created at
McConnell Brain maging Centre of the Montreal Neurological
Institute. Following this procedure, the files were anonymized.
A number of image processing steps were performed in order
to make MRI data usable for image analysis. The first step
was the intensity non-uniformity correction (Sled et al., 1998).
These images were then linearly registered (aligned) into stereo-
taxic coordinates (Collins et al., 1994) based on the Talairach
atlas (Talairach and Tournoux, 1988). The linear registration
to Talairach coordinates was accomplished through 3D cross-
correlation between a given volume and an average MR brain
image previously converted into the Talairach coordinate system
(Collins et al., 1994). After the registration the images had the
same size and orientation, allowing for direct anatomical com-
parisons between subjects. A second non-uniformity correction
was performed after the registration, which helped to remove any
residual non-uniformity artifacts.
Every voxel in a non-uniformity corrected and registered
image was then classified into one of the three classes: cerebro-
spinal fluid (CSF), gray matter (GM), and WM using an auto-
mated tissue classification algorithm (Zijdenbos et al., 1998).
Subsequently, cortical surface extraction from the tissue-classified
images was performed, resulting in a 3D reconstruction of the
cortical surface. Next, the skull and scalp were removed in the
tissue-classified images using the 3D surface extraction as a mask
in order to obtain the tissue volumes of the whole brain. Thus, the
volumes of CSF, GM, and WM reported in this study were calcu-
lated using the tissue-classified images, which excluded the skull,
scalp, cerebellum, and brainstem. The combination of the GM
andWMwas used as the whole brain volume in the VBR analysis.
The hippocampi were manually outlined using Analyze TM
8.1 (Brain Imaging Resource, Mayo Clinic, MN) by an experi-
enced tracer (JM) from coronally orientated MR images in the
anterior-posterior direction. Calculations of volumes were com-
puted automatically by multiplying the number of voxels traced
in each slice, by their depth (i.e., slice thickness). As described by
Watson et al. (1992, 1997), the anterior tip of the HPC until the
slice before the opening of the crux of the fornix was measured
as the HPC head and body and included the subiculum, CA1-
areas, and dentate gyrus. The HPC tail was measured from the
slice immediately posterior to that which represented the last slice
according to the Watson protocol (see Maller et al., 2007 for a
more detailed description of this procedure) (Maller et al., 2007).
The CC was manually traced on the midline sagittal slice of the
T1 images using anatomical landmarks in an hierarchical order
on a Windows XP Professional workstation (Core2Duo CPU,
2GIG RAM) using the Region of Interest module within ana-
lyzetm 8.1 (Brain Imaging Resource, Mayo Clinic, MN, USA).
The landmarks based on the midline sagittal slice were, first, no
WM or only minimal WM in the cortical mantle surrounding the
CC, second, the interthalamic adhesion, and third, the transpar-
ent septum and the visibility of the aqueduct of Sylvius. To adjust
for total brain volume, total midsagittal CC area and every sub-
regional area in the analyses data were normalized by dividing by
each individual’s total intracranial volume (ICV). ICV was calcu-
lated from the total of GM, WM, and cerebrospinal fluid volumes
which were estimated from processing the T1-weighted scans
through FSL 4.0 (Analysisgroup, 2012), using the FAST module.
Analyses
Percentage of people showing significant decline in volume. As
noted above, patients were classified as “decliners” if they showed
atrophy in parenchymal tissue at a threshold of at least 2 z-scores
below that of controls. (Note that we use the term “below” here
rather than “greater than” for clarity of exposition.) We calculated
a z-score for each patient participant using the following method:
First, for each structure and substructure, percent change from
time 1 to time 2 was calculated for patients and controls using the
following formula: [t2− t1/(t1+ t2)] ∗ 100. Second,monthly per-
cent change was then calculated in order to compare subjects with
differing temporal gaps between scans. Third, a z-score was cal-
culated for each patient using his/her observed score (i.e., percent
change per month), the expected score (i.e., mean monthly per-
cent change for controls), and the standard deviation for monthly
percent change in the control group. We used a conservative z-
score cut-off to classify decliners. Only if the patient was at least 2
z-scores below that of controls was he/she classified as a decliner.
This enabled us to compute the percentage of decliners in our
sample, in order to address the primary objective of our study.
Relative vulnerability of decline of structures/sub-structures and
pattern of deterioration. To examine whether structures were
equally vulnerable to decline or whether the number of decliners
varied across structures, we calculated 95% confidence intervals
for each proportion of decliners across structures, and substruc-
tures. To examine whether decline in one structure was associated
with decline in another, we calculated PHI coefficients and their
95% confidence intervals between structures and between sub-
structures. This enabled us to measure the degree of overlap
within subjects in decliner classification across the structures (i.e.,
is there a correlation between those classified as decliners and
non-decliners in one structure and those in another?). The PHI
coefficient is a measure of association for two binary variables,
interpreted similarly to the Pearson Correlation Coefficient.
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Presentation of findings. Results are presented by each of the
three research questions: (1) the overall percentage of people
showing decline on at least one structure, and the number of
structures on which subjects declined; (2) the relative vulnera-
bility of structures (i.e., respective number of decliners in each
structure), and (3) the pattern of atrophy (i.e., whether decline in
one structure was associated with decline in another).
RESULTS
DEMOGRAPHIC COMPARISONS BETWEEN CONTROLS AND PATIENTS
There was no significant difference between the patients and con-
trols for age, t = 0.897 (df = 72), p = 0.373, Cohen’s d = 0.211.
The controls had significantly more education than the patients,
t = −4.25 (df = 72), p < 0.001, Cohen’s d = −1.00.
DECLINERS: PERCENTAGE OF PATIENTS WHO SHOW ATROPHY THAT
IS AT LEAST 2 z-SCORES BELOW THAT OF CONTROLS
Table 2 shows the monthly percent atrophy in the control group.
The control group monthly percent changes were extremely
small, with all scores close to 0, consistent with stability over
time. [Note that while the primary aim of the study was to ascer-
tain the percentage of decliners in our sample, we have included
patient means with unpaired t-test results (all assuming unequal
variances based on Levene’s tests) to permit group mean compar-
isons]. These illustrate highly significant group differences.
Table 3 shows that compared to the normative group, over
96% of patients showed decline in at least one region. The major-
ity (75%) showed decline in at least three of the four regions
measured.
In Table 4 the absolute number and percentage of decliners
by structure are presented. Over 70% of patients showed atro-
phy within each of the right and left HPC, the CC and the whole
brain; moreover, the lower bounds of the confidence intervals for
Table 2 | Percent decline (by group) across structures and
substructures.
Structure Percent atrophy Percent atrophy
per month in per month in
healthy control patients (N = 56)
participants (N = 12)
VBRa 0.18 (0.21) 1.32 (1.21)*****
HPC-L head −0.008 (0.03) −0.300 (0.63)**
HPC-L body −0.004 (0.04) −0.364 (0.59)*****
HPC-L tail 0.054 (0.08) −0.676 (1.44)*****
HPC-L total −0.002 (0.02) −0.348 (0.48)*****
HPC-R head 0.004 (0.03) −0.248 (0.60)**
HPC-R body 0.005 (0.03) −0.331 (0.83)**
HPC-R tail −0.023 (0.05) −0.662 (1.05)*****
HPC-R total 0.002 (0.03) −0.324 (0.53)*****
CC genu −0.14 (0.11) −0.855 (1.24)*****
CC body 0.09 (0.09) −0.765 (1.33)*****
CC splenium 0.08 (0.09) −0.805 (0.81)*****
CC total −0.02 (0.04) −0.812 (0.88)*****
aPositive change for VBR denotes atrophy.
**P < 0.005; *****P < 0.00001.
each of these values was greater than 50%. Therefore, the results
strongly support our hypothesis that more than 50% of patients
would show atrophy of the brain.
RELATIVE VULNERABILITY TO DECLINE OF STRUCTURES AND
SUB-STRUCTURES
Examining similarities and differences across structures in the
number of decliners, Table 4 shows that, the highest absolute
number of decliners is in VBR; this is not surprising as VBR is
an index of total brain volume loss that subsumes all structures.
However, none of the structures (including VBR) differed signifi-
cantly from one another with respect to the number of decliners,
with confidence intervals overlapping substantially. Within the
substructures, it is interesting to note that only the genu of the
CC was different from its respective sub-structures, with signif-
icantly fewer decliners than in either the body or the splenium.
These results did not support our hypothesis that the hippocam-
pus, and particularly the hippocampal head would show greatest
vulnerability.
PATTERN OF ATROPHY ACROSS STRUCTURES
Examining whether atrophy across structures and sub-structures
was related, we examined the association between decliners. If a
patient showed atrophy across time on one structure, were they
likely to also show atrophy on another structure? Table 5A shows
the PHI coefficients and their 95% confidence intervals between
regions measured. There was an overarching relationship, that
Table 3 | The number of patients who show atrophy.
Number/(percentage) of decliners
Decline in at least 1 structure 54/56 (96.4%)
Decline in 4/4 structures 22/56 (39.3%)
Decline in 3/4 structures 20/56 (35.7%)
Decline in 2/4 structures 8/56 (9%)
Decline in 1/4 structures 4/56 (7%)
Decline in 0/4 structures 2/56 (3.6%)
Table 4 | The number of patients who show decline in each structure
and substructure.
Structure/ Number/(percentage) of Lower and upper 95%
substructure decliners by structure CI at 2 z-score < controls
VBR 45 (80.4) 67.6–89.9
HPC-L head 31 (55.4) 41.5–68.7
HPC-L body 24 (42.9) 29.7–56.8
HPC-L tail 32 (57.1) 43.2–70.3
HPC-L total 40 (71.4) 57.8–82.7
HPC-R head 38 (67.9) 54.0–79.7
HPC-R body 39 (69.6) 55.9–81.2
HPC-R tail 36 (64.3) 50.4–76.6
HPC-R total 41 (73.2) 59.7–84.2
CC genu 26 (46.4)* 33.0–60.3
CC body 42 (75.0) 61.6–85.6
CC splenium 42 (75.0) 61.6–85.6
CC total 43 (76.8) 63.6–87.0
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Table 5A | PHI coefficients across the structures measured.
PHI coefficients (95% CI)
VBR HPC-L total HPC-R total CC total
VBR – r = −0.01 (CI = −0.28–0.25) r = 0.31* (CI = 0.05–0.53) r = 0.37* (CI = 0.12–0.57)
HPC-L total – – r = 0.33* (CI = 0.08–0.55) r = 0.03 (CI = −0.24–0.29)
HPC-R total – – – r = 0.15 (CI = −0.12–0.39)
is, significant overlap, between VBR with both the CC and the
right (but not left) HPC. The right and left hippocampus also
overlapped significantly. There was no relationship between the
CC and the hippocampi. These results partially supported our
hypotheses, namely a relationship between VBR and individual
structures, and the absence of relationship between some (though
not all) of the structures measured.
Table 5B presents the PHI coefficients and their 95% confi-
dence intervals between substructures. Here, significant overlap
was observed between the right hippocampus head and tail, and
between the genu and body and the genu and splenium of the CC,
findings which overall did not support our hypothesis.
DISCUSSION
The primary purpose of the current study was to gain a better
understanding of the scale of atrophy in the chronic phase of
TBI. Our cohort was a Canadian sample of patients with brain
injuries ranging from complicated mild to severe. More than 96%
of our sample showed atrophy over time in at least one region
and the large majority showed atrophy in at least three of the four
regions measured. Therefore, these findings indicate substantive
atrophy—we employed a threshold of at least two z-scores below
that of controls—across several structures. Given the relation-
ship between sub-acute atrophy and behavioral and functional
outcomes (Sidaros et al., 2008, 2009; Farbota et al., 2012), and
between total brain volume loss and clinical impairment (Tate
et al., 2011), these findings are clinically concerning, especially
as brain atrophy is a known predictor of Alzheimer’s Disease
(Frisoni et al., 2010).
A secondary purpose of the study was to begin to charac-
terize this chronic atrophy by examining two related features
of the data: (i) the extent to which the number of declin-
ers in each structure and sub-structure differed, allowing us
to evaluate preliminarily the relative vulnerability of structures
examined, and (ii) the extent to which decline in one struc-
ture was associated with decline in another. With regard to
the first question, we found few differences in the number of
decliners across structures and sub-structures, with only the
genu differing significantly from the other sub-structures of
the CC. Thus, contrary to our hypothesis, the findings in the
small number of regions examined in our study do not sug-
gest that one region is more vulnerable to chronic volume loss
than another, with the exception of the genu. However, it is
possible that limited power may have elevated Type II errors;
given the rather large confidence intervals secondary to sam-
ple size, the results may under-represent differences between
structures.
Table 5B | PHI coefficients for sub-structures of the left and right
hippocampus and the corpus callosum.
PHI coefficients (95% CI)
HPC-L head HPC-L body HPC-L tail
HPC-L head – r = −0.02 r = 0.02
(CI = −0.28–0.24) (CI = −0.24–0.28)
HPC-L body – – r = −0.05
(CI = −0.31–0.21)
HPC-R head HPC-R body HPC-R tail
HPC-R head – r = 0.13 r = 0.29*
(CI = −0.14–0.38) (CI = 0.02–0.51)
HPC-R body – – r = 0.16
(CI = −0.11–0.40)
CC genu CC body CC splenium
CC genu – r = 0.29* r = 0.37*
(CI = 0.03–0.51) (CI = 0.12–0.58)
CC body – – r = 0.14
(CI = −0.13–0.39)
Regarding the second question, we found more associations
across structures than we had predicted. Subjects showing atro-
phy in the whole brain also showed atrophy in other structures
measured (i.e., CC and right HPC) as expected, which likely does
not speak to underlying mechanisms, but rather to VBR’s inclu-
sive relationship with the other structures measured. However, we
also found that those who declined in one HPC were more likely
to also decline in the other. Within the sub-structures, those who
declined in the right HPC head were more likely to decline in the
tail, and those who declined in genu of the CC were more likely to
decline in the body and the splenium. It is important to note that
wide confidence intervals secondary to sample size bias the find-
ings in favor of Type II errors, and that these findings may actually
underestimate the degree of association between the structures.
These findings offer some direction for future research
into mechanisms. A great deal of research has examined
the acute primary and secondary mechanical, chemical, and
electrophysiological changes in the brain following TBI, which
in more serious injuries are ultimately associated with necrotic
or apoptotic death (Povlishock and Katz, 2005; Griesbach et al.,
2007). In contrast, there has been relatively limited research
directly investigating mechanisms of later atrophy of the brain
(but see Johnson et al., 2013; Smith et al., 2013).
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MECHANISMS OF ATROPHY IN THE CHRONIC STAGE OF TBI
In broad strokes, atrophy in the chronic stages of injury may
reflect volume loss, neuronal death or a reduction in neuronal
proliferation and/or survival. Cell death may occur due to delayed
apoptotic mechanisms (Colicos et al., 1996; Bramlett et al.,
1997a,b; Dixon et al., 1999; Williams et al., 2001; Coulson et al.,
2008) secondary to trans-neuronal degeneration (Gennarelli and
Graham, 1998; Tate and Bigler, 2000) arising from disconnec-
tions within or between functionally related structures (Tate and
Bigler, 2000; Duering et al., 2012; Bigler, 2013b). Volume loss
may reflect decreased complexity of the neuropil, with decreased
spines, synapses and arborization or reduced fluid as a result of
diminished protein production. Vascular changes might also con-
tribute to volumetric changes over time. For example, reduced
functional hyperemia (because of reduced neuronal demand)
would reduce blood volume as would disrupted neurovascular
coupling. A mechanism receiving increasing scientific attention
for chronic stage losses in TBI is persisting inflammation, associ-
ated with cytokine release and microglial activation (Gentleman
et al., 2004; Rodriguez-Paez et al., 2005; Johnson et al., 2013;
Smith et al., 2013). Genetic causes of poorer clinical outcomes
have been advanced for a number of years (Ponsford et al., 2011).
A highly probable cause of volume losses are the synergistic effects
of aging and TBI, as described in detail by Bigler (2013b); such
effects may exacerbate the burden of normal and pathological
aging, and thereby account for observed volume losses, with such
losses also hastening the onset of dementia. Links between TBI
and dementia are being increasingly made (Fakhran et al., 2013),
with proteins implicated in dementias (e.g., amyloid-beta, amy-
loid precursor protein, tau), for example, found to accumulate in
damaged axons and other neuronal compartments in the chronic
stages of TBI (Bramlett et al., 1997b; Smith et al., 2003; Uryu et al.,
2007; Johnson et al., 2012; Bennett et al., 2013).
Importantly, these candidate mechanisms of atrophy are
empirically testable. Ultimately, an understanding is needed of
whether a single mechanism or multiple mechanisms influence
atrophy, whether different mechanisms affect different regions,
and if multiple mechanisms do influence atrophy, whether they
are additive or synergistic.
The findings in the current study favor some mechanisms
over others, helping at least to constrain hypotheses for future
research. The ubiquity of atrophy across patients would not sup-
port an exclusive genetic explanation of atrophy; for example,
base rates of the e-4 allele that has been implicated in the relation-
ship between TBI and dementia are considerably lower than the
96% incidence of patients who showed volume loss in this study.
With regard to neuroinflammation, Johnson et al. (2013)
showed evidence of increasing neuroinflammation in the CC
from the sub-acute to the more chronic stages of injury (i.e., 2
weeks to 1 year vs. > 1–18 years post-injury), and inflamma-
tion correlated with WM integrity losses and visible pathology.
The prevalence of unequivocal markers of neuroinflammation
appeared to be substantively lower than the 76.8% of patients in
our study showing CC volume loss. However, neuroinflammation
is likely one of multiple causes of volume loss in our study.
In humans, the identification of behavioral factors that may
exacerbate or buffer against volume loss is of high importance
given the potential for clinical intervention. It has been postulated
that a downward spiral of negative neuroplastic change secondary
to disuse may play a role in chronic decline (Evans, 2008; Miller
et al., 2013). Supporting this putative mechanism, our group
observed a significant negative correlation between self-reported
hours of environmental enrichment in the first year post-injury
and the degree of hippocampal atrophy observed from 5 to 20
months post-injury (Miller et al., 2013). Compounding disuse
is physiological disconnection of healthy tissue from damaged
tissue. Given that all of our patients had sustained brain dam-
age and were therefore at risk of both disconnection and disuse,
and moreover, that the CC and hippocampus are frequently
affected acutely, and are associated with discrete cognitive func-
tions, this explanation is consistent with the high prevalence of
chronic atrophy observed. Within the substructures of the (right)
hippocampus, the significant association observed is consistent
with this interpretation, with the unique pattern of intercon-
nectivity within the hippocampus meaning that damage to one
area may deafferent another; if the disconnected tissue does not
functionally re-organize, then it is vulnerable to transneuronal
degeneration (McCarthy, 2003; Amaral et al., 2008).
However, other aspects of our findings do not support the
interpretations above. For example, we found that hippocampal
volume loss on the right was positively associated with vol-
ume loss on the left. Experience-dependent volume increases in
the hippocampus (Draganski et al., 2006; Maguire et al., 2006)
would have predicted that greater reliance on the less damaged
hippocampus would result in volumetric increases to it, giving
rise to a negative association between hippocampi. The positive
association between hippocampi suggests a common mechanism
deleteriously affecting both. One such mechanism is reduction
in new neuronal growth, survival and integration. As is the case
for many TBI patients, many of the patients in our cohort at 5
months post-injury and later, had residual physical impairments,
reduced volition, had neither returned to work or school, were
less socially engaged, and had limited access to resources (Frasca
et al., 2013), Therefore, many underwent less physical activity,
and many were engaged in less cognitively demanding activity.
Since physical and cognitive enrichment have been associated,
respectively, with enhanced neuronal proliferation and survivor-
ship (Curlik and Shors, 2010, 2013), this reduced enrichmentmay
have offset hippocampal growth. Moreover, widespread dam-
age to networks might have further impeded integration of new
neurons.
The array of possible interpretations for these findings indi-
cates that much further research is needed to understand
mechanisms of atrophy in sub-acute and chronic TBI. Such
an understanding is critical for the development of treatment
research to avert or abate this atrophy.
There were limitations of the current study. The size of the
control group was relatively small and may have compromised
the reliability of our findings. As well, because the timelines of the
two assessments of controls and patients differed, we calculated
monthly percent change to compare patients with controls. This
calculation assumes a linear month-to-month change, which is
not substantiated. There were significant education, but not age,
differences between the patient and control groups. However, we
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speculate that this difference did not contribute to our findings.
In a previous study by our group Miller et al. (2013) using over-
lapping participants, there was no relationship between years
of education and degree of hippocampal atrophy. Moreover,
the weight of evidence suggests that education confers protec-
tion against the clinical (cognitive) expression of disease, but
not against the development of neuropathology or neurodegen-
eration itself (Members et al., 2010). As well, our findings do
not permit us to distinguish between cell death versus volume
loss without death. Other methodological approaches, including
neuropathological ones, are needed to examine this distinction.
CONCLUSIONS
In the chronic stage of moderate-severe atrophy, loss of vol-
ume is substantive and ubiquitous across patients. Changes may
be attributable to tissue shrinkage—the result of lost neuropil,
protein and/or fluids—or to cell death, with disconnection and
disuse, inflammation and delayed apoptosis contributing inde-
pendently or interactively. Environmental enrichment could play
a role in offsetting these changes, and in the chronic stages of
injury is a “no-harm” intervention that warrants investigation.
Further research is needed to identify precise mechanisms of atro-
phy that would help us to develop targeted clinical interventions.
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